Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients

被引:0
|
作者
Philippe Anker
Hugh Mulcahy
Xu Qi Chen
Maurice Stroun
机构
[1] University of Geneva,Laboratoire de Biochimie et Physiologie végétale, Pavillon des Isotopes
[2] Digestive Diseases Research Centre,undefined
[3] St Bartholomew's and Royal London School of Medicine and Dentistry,undefined
来源
关键词
mutation detection; microsatellite DNA; circulating DNA; cancer; plasma/serum;
D O I
暂无
中图分类号
学科分类号
摘要
Small amounts of free DNA circulate in both healthy and diseased human plasma/serum, and increased concentrations of DNA are present in the plasma of cancer patients. Characteristics of tumour DNA have been found in genetic material extracted from the plasma of cancer patients. These features include decreased strand stability and the presence of specific oncogene, tumour suppressor gene and microsatellite alterations. Point mutations of the ras genes have been detected in the plasma DNA of patients suffering from haematopoetic malignancies, colorectal and pancreatic cancer, sometimes prior to clinical diagnosis. Rearranged immunoglobulin heavy chain DNA has been found in the plasma of patients with non-Hodgkins lymphoma and acute B cell leukaemia. Microsatellite instability, expressed either as a new allele or a loss of one allele (LOH) occurs in the plasma and serum DNA of patients suffering from head and neck, lung and renal cell cancer. The results obtained in many different cancers have opened a new research area indicating that plasma DNA might eventually be a suitable target for the development of non-invasive diagnostic, prognostic and follow-up tests for cancer.
引用
收藏
页码:65 / 73
页数:8
相关论文
共 50 条
  • [1] Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients
    Anker, P
    Mulcahy, H
    Chen, XQ
    Stroun, M
    CANCER AND METASTASIS REVIEWS, 1999, 18 (01) : 65 - 73
  • [2] Detection of circulating tumour DNA in the blood of cancer patients
    Hainaut, P
    M S-MEDECINE SCIENCES, 2000, 16 (03): : 446 - 446
  • [3] Methylation-specific PCR (MSP) for detection of tumour DNA in the blood plasma and serum of patients with prostate cancer
    Goessl C.
    Müller M.
    Miller K.
    Prostate Cancer and Prostatic Diseases, 2000, 3 (Suppl 1) : S17 - S17
  • [4] Quantification of circulating DNA in the plasma and serum of cancer patients
    Taback, B
    O'Day, SJ
    Hoon, DSB
    CIRCULATING NUCLEIC ACIDS IN PLASMA/SERUM III AND SERUM PROTEOMICS, 2004, 1022 : 17 - 24
  • [5] Detection of tumour DNA in serum of colorectal cancer patients
    DeKok, JB
    VanSolinge, WW
    Ruers, TJM
    Roelofs, RWHM
    VanMuijen, GNP
    Willems, JL
    Swinkels, DW
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1997, 57 (07): : 601 - 604
  • [6] Detection of KRAS mutations in circulating tumour DNA from plasma and urine of patients with colorectal cancer
    Ohta, Ryo
    Yamada, Takeshi
    Sonoda, Hiromichi
    Matsuda, Akihisa
    Shinji, Seiichi
    Takahashi, Goro
    Iwai, Takuma
    Takeda, Kohki
    Ueda, Koji
    Kuriyama, Sho
    Miyasaka, Toshimitsu
    Yokoyama, Yasuyuki
    Hara, Keisuke
    Yoshida, Hiroshi
    EJSO, 2021, 47 (12): : 3151 - 3156
  • [7] Droplet Digital PCR for detection of circulating tumour DNA in blood of head and neck cancer patients
    Van Ginkel, J. H.
    Huibers, M. M. H.
    Van Es, R. J. J.
    De Bree, R.
    Willems, S. M.
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 : 46 - 46
  • [8] Detection of circulating tumour cells in the peripheral blood of patients with primary breast cancer
    Rack, B.
    Schindlbeck, C.
    Hofinann, S.
    Tulusan, H.
    Himsl, I
    Beckmann, M. W.
    Janni, W.
    Friese, K.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (05) : 502 - 502
  • [9] Detection and molecular characterization of circulating tumour cells in blood of breast cancer patients
    Wagner, S.
    Schneeweiss, A.
    Wiemann, S.
    Beissbarth, T.
    Arlt, D.
    ONKOLOGIE, 2010, 33 : 14 - 14
  • [10] The detection of circulating tumour cells in blood of metastatic breast cancer patients is of prognostic relevance
    O. Zach
    B. Zellhofer
    M. Födermayr
    H. Kasparu
    M. Girschikofsky
    W. Hehenwarter
    H. Hauser
    R. Függer
    W. Havlicek
    D. Lutz
    memo - Magazine of European Medical Oncology, 2008, 1 (4)